|
|
  |
| WHAT
IS JUBLIA (efinaconazole)ANTIFUNGAL TOPICAL NAIL SOLUTION? |
| Jublia
Nail Lacquer is a NEW medical breakthrough: FDA approved TOPICAL nail solution
for TOENAIL fungal infections: approved by the FDA for the treatment of
mild to moderate toenail infections in the immunocompetent patient.
Jublia is a nail solution brushed on the nail to treat toenail fungus infections,
onychomycosis. Jublia is a NEW, FDA approved prescription topical solution
that is applied on, around and under the toenail - it reaches the site
of onychomycosis to fight the fungus that lives beneath the nail. The active
ingredient in Jublia (efinaconazole) Topical Solution cream is efinaconazole
10%, specifically formulated to reach the site of onychomycosis, to treat
toenail fungus. Unlike Lamisil tablets nail fungal medications taken
orally which can affect the entire body, Jublia (efinaconazole) Topical
Solution works from the outside directly on the nail fungus. Lamisil tablets
can result in liver failure. Nail the infection from the outside in with
Jublia Topical Nail solution prescription. |
| WHAT
IS A NAIL FUNGUS INFECTION, ONYCHOMYCOSIS? |
| Onyhomycosis
or nail fungus infection is a medical condition that is treatable.
Nail fungal infections are caused by dermatophytes, a fungus that infects
skin, nails and hair. Jublia is FDA approved only for the treatment of
TOENAIL infections. Most often the fungus enters just under the top of
the nail and moves steadily toward the cuticle, the white half moon area.
The infected nails become discolored, yellowish-brown, thickened, misshaped
and eventually (if left untreated) separate from the nail bed and the nail
crumbles off. |
| WHO
IS SUSCEPTIBLE to NAIL FUNGAL INFECTIONS? |
| Over
30 million Americans are affected. Nail fungus infection is most
commonly seen on the toenails of men and the fingernails of women.
Most infections occur in those between the ages of 40 to 65 but anyone
can become infected. Some individuals have an inherited tendency to have
nail fungal problems. Also, individuals with a compromised immune
system and certain types of long-term conditions such as HIV-positive,
diabetes etc. are at an increased risk. The following are some environmental
factors increasing the risk of nail fungal infections: Continuous exposure
of hands and feet to moisture, shoes fitting too tightly, not changing
shoes often enough, injury to toe or fingernail. Jublia is FDA approved
for the treatment of TOENAIL fungus. |
WHY
DO I NEED TO TREAT A MILD NAIL INFECTION?
IF LEFT UNTREATED
WILL IT GO AWAY BY ITSELF? |
| Onychomycosis
is a progressive fungal infection. The fungus destroys tissue and
organic debris accumulates under the nail leading to nail changes beginning
with slight thickening and discoloration. If left untreated the nail
plate eventually separates from its nail bed and crumbles off and the infections
spreads to other nails. The condition progresses from what initially
appears to just be a "cosmetic" discoloration of the nail to a painful
debilitating condition affecting ones ability to walk or use their fingers. |
|
WHO QUALIFIES
FOR AN ONLINE JUBLIA CONSULTATION?
|
| If
you have previously been diagnosed by a health care profession as suffering
from mild to moderate nail fungal infection (click
here for photos of nail fungal infection) you
may finally have find a safe and simple solution to the embarrassing condition
of discolored, thickened and hardened nails due to a dermatophyte fungal
infection. Jublia antifungal nail solution is applied directly at the site
of the fungal infection and may work for you when other treatments have
failed. Jublia prescription is not for those with severe fungal infections
involving the entire nail. Mild to moderate infections are those involving
only several nails and more than half of the nail may be affected but NOT
including the cuticle white half moon area at the top of the nail where
it joins onto the finger. If you have many nails affected, the entire nail
is involved, brittle and has lifted off from the nail bed and is accompanied
by ulceration of surrounding skin and pain you do NOT qualify for an online
consultation, you must seek immediate medical attention from your own physician.
If you have long-term conditions affecting your immune system such as diabetes,
organ-transplant recipient, HIV-positive, regular user of steroids or steroid
inhalers you do not qualify for an online consultation. |
|
WHEN &
HOW OFTEN DO I USE JUBLIA (efinaconazole) TOPICAL SOLUTION?
|
Jublia
Topical Solution is applied only once a day for 48 weeks to the affected
nails with the applicator brush provided. Once daily, set a schedule -
When you wake up in the morning
or After you shower*
or Just before bed
*Wait
for at least 10 minutes after showering, bathing, or washing before applying
JUBLIA. |
|
HOW LONG BEFORE
I SEE RESULTS?
|
  
Nail
infections are very difficult to cure and it may take many months of treatment
to see the effects as toenails grows very slowly. Toenails can take 12
months or longer to completely regrow. Additionally, the time it takes
for a healthy nail to grow back varies from person to person. Even after
the fungus has been eliminated, nail regrowth can sometimes take a year
or longer. But don't despair and discontinue treatment if you
do not see improvement right away. It may take 6 months or longer to start
to see improvement. 48 weeks of treatment is required for a cure which
is defined as 10% or less residual nail involvement. |
|
HOW IS JUBLIA
DIFFER FROM THAN OTHER NAIL FUNGAL TREATMENTS?
|
| Nail
fungus are very difficult to clear up and if left untreated will only progress.
Jublia (efinaconazole) Topical Solution differs from oral medications because
it is applied directly to the site of the infected nail and it does NOT
have systemic effects. Since antifungal nail treatment needs to be
continued for many months, Jublia is advantageous as it has no systemic
toxicity and is much better tolerated and safer than other available treatments.
Jublia is a NEW FDA-approved topical prescription treatment proven effective
for treating mild to moderate TOENAIL fungal infections in immunocompetent
candidates. Jublia is NOT approved for fingernail infections. |
|
HOW DOES JUBLIA
DIFFER FROM PENLAC NAIL LACQUER
|
| Ciclopirox
nail lacquer (Penlac) was the only topical treatment approved by the Food
and Drug Administration for the treatment of onychomycosis in the United
States, until the Jublia was FDA approved. Penlac (ciclopirox) nail lacquer
has reported complete cure rates of only 5.5-8.5%, requires frequent nail
debridement and patients have to use alcohol to remove excess buildup of
lacquer from the ventral aspect of the nail plate to avoid additional infection.
Jublia has show complete cure rates of 15-17%. Jublia, efinaconazole,
represents the next generation of topical therapies for at-risk patients. |
|
CAN
JUBLIA TOPICAL SOLUTION BE USED WITH OTHER ANTIFUNGAL NAIL TREATMENTS OR
BE USED WITH NAIL POLISH?
|
| Jublia
Topical solution is NOT recommended to be used with any other systemic
antifungal agents for nail fungus infection as there are no studies to
determine their interactions. Also DO NOT use nail polish, acrylic
nails, or any other cosmetic nail products during treatment regimen with
Jublia. Avoid pedicures, use of nail polish and cosmetic nail products
while using JUBLIA. |
| WHAT
IF I MISS A JUBLIA (efinaconazole) TOPICAL SOLUTION APPLICATION? |
| If
you miss a Jublia (efinaconazole) Topical Solution application it is best
to just skip the missed dose and continue on with your daily nail care
regimen. Never double-up or use a greater amount to make- up
for missed dose, this may only enhance the likelihood of more severe skin
irritations. |
| WHAT
ARE THE SIDE EFFECTS OF JUBLIA (efinaconazole) TOPICAL SOLUTION? |
| Jublia
Nail solution does not have systemic effects when used appropriately.
There are No know drug interactions and No laboratory monitoring is needed.
The majority of patients using Jublia (efinaconazole) Topical Solution
experience no side effects, and any side effects are mild if any. The most
common side effects seen in about 2% of patients during clinical trials
were ingrown toenails, redness, itching, swelling, burning or stinging,
blisters, and pain. Jublia may cause other side effects. If
nails start to change shape or you have prolonged swelling and pain around
your nails, discontinue use and contact your regular doctor. If you
get the medication in your eyes, rinse immediately with water and seek
immediate emergency treatment! |
WHO SHOULD NOT USE Jublia
NAIL LACQUER?
WHAT ARE THE CONTRAINDICATIONS
FOR Jublia (efinaconazole) Topical Solution?
|
-
Do NOT use
Jublia (efinaconazole) Topical Solution if you are pregnant or attempting
to become pregnant or breast feeding.
-
Do NOT use
Jublia (efinaconazole) Topical Solution if you are breast feeding.
-
Do NOT use
Jublia (efinaconazole) Topical Solution if you are allergic to any of the
ingredients: efinaconazole in a solution base alcohol, butylated hydroxytoluene,
C12-15 alkyl lactate, citric acid, cyclomethicone, diisopropyl adipate,
disodium edetate, and purified water.
-
Do Not use
on skin other than that immediately adjacent to infected TOENAIL
-
Do NOT use
on advanced severe fungal nail infections involving the entire nail
-
Do NOT us if
have a history of immunosuppression, history of recurrent shingles, on
cancer chemotherapy, HIV-positive, organ transplant recipient, diabetic,
diabetic neuropathy, on anti seizure medication to control epilepsy, use
topical corticosteroids on a repeated monthly basis, use steroid inhalers
on a regular basis - you need to be constantly monitored by a physician
during treatment as there is high potential of complications and superinfection.
-
Do NOT use
in eyes. Do NOT use orally. Do NOT use on mucous membranes on intravaginal.
-
Not approved
for pediatric use
-
Do NOT use
Jublia on fingernails.
-
Jublia FDA-approved
for the treatment of TOENAIL FUNGAL infections ONLY!
|
| We
will not prescribe Jublia (efinaconazole) Topical Solution to anyone under
the age of 18. Also Jublia (efinaconazole) Topical Solution should NOT
be used by pregnant women or women who are breast feeding. Jublia (efinaconazole)
Topical Solution is ONLY approved for use for fungal infections of the
toenails. |
|
|
|